We can't find the internet
Attempting to reconnect
31010.1 IP-LS
31010.1 IP-LS
Résumé
Translational development of a medical device to treat microvascular obstruction in heart attack patients
Textes supplémentaires
Abstract
CorFlow is addressing reperfusion in patients with acute myocardial infarction by developing the Controlled Flow Infusion technology which enables measuring the status of the coronary microcirculation and which provides methods for controlled infusion of therapeutic agents.
Participants
Jon H. Hoem
Wirtschaftspartner
jhoem@corflow-therapeutics.ch
CorFlow Therapeutics AG CHE-320.873.257 Jon H. Hoem Neuhofstrasse 3D 6340 Baar ZG CH
Dominik Obrist
Kontaktperson
dominik.obrist@artorg.unibe.ch
Universität Bern ARTORG Center Dominik Obrist Murtenstrasse 50 3008 Bern BE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-11-30
- Date de fin
- 2022-03-31
- Coûts totaux approuvés
- CHF 1858349.40
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T115 Medical technology 100.0%